Genome-wide association study of glioma and meta-analysis

Human Genetics

Volumn 131, Issue 12, 2012, Pages 1877-1888

  Rajaraman, Preetha ^a   Melin, Beatrice S ^b   Wang, Zhaoming ^a,b,c   McKean Cowdin, Roberta ^d   Michaud, Dominique S ^e,f   Wang, Sophia S ^g   Bondy, Melissa ^h   Houlston, Richard ⁱ   Jenkins, Robert B ^j   Wrensch, Margaret ^k   Yeager, Meredith ^a,c   Ahlbom, Anders ^l   Albanes, Demetrius ^a   Andersson, Ulrika ^b   Freeman, Laura E Beane ^a   Buring, Julie E ^m   Butler, Mary Ann ⁿ   Braganza, Melissa ^a   Carreon, Tania ⁿ   Feychting, Maria ^l   Fleming, Sarah J ^o   Gapstur, Susan M ^p   Gaziano, J Michael ^m,q   Giles, Graham G ^r,s   Hallmans, Goran ^b   Henriksson, Roger ^b   Hoffman Bolton, Judith ^t   Inskip, Peter D ^a   Johansen, Christoffer ^u   Kitahara, Cari M ^a   Lathrop, Mark ^v,w   Liu, Chenwei ^c   Marchand, Loic Le ^x   Linet, Martha S ^a   Lonn, Stefan ^l,y   Peters, Ulrike ^z,aa   Purdue, Mark P ^a   Rothman, Nathaniel ^a   Ruder, Avima M ⁿ   Sanson, Marc ^ab   Sesso, Howard D ^m   Severi, Gianluca ^r,s   Shu, Gianluca ^ac   Simon, Matthias ^ad   Stampfer, Meir ^m,ae   Stevens, Victoria L ^p   Visvanathan, Kala ^t,af   White, Emily ^z,aa   Wolk, Alicja ^l   Zeleniuch Jacquotte, Anne ^ag   Zheng, Wei ^ac   Decker, Paul ^j   Enciso Mora, Victor ⁱ   Fridley, Brooke ^j   Gao, Yu Tang ^ah   Kosel, Matthew ^j   Lachance, Daniel H ^j   Lau, Ching ^h   Rice, Terri ^k   Swerdlow, Anthony ⁱ   Wiemels, Joseph L ^k   Wiencke, John K ^k   Shete, Sanjay ^ai   Xiang, Yong Bing ^ah   Xiao, Yuanyuan ^k   Hoover, Robert N ^a   Fraumeni, Joseph F ^a   Chatterjee, Nilanjan ^a   Hartge, Patricia ^a   Chanock, Stephen J ^a,c   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b UMEÅ UNIVERSITY   (Sweden)

^c SAIC FREDERICK INC   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e BROWN UNIVERSITY   (United States)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^h BAYLOR COLLEGE OF MEDICINE   (United States)

ⁱ INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^j MAYO CLINIC   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l KAROLINSKA INSTITUTE   (Sweden)

^m BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁿ NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^o UNIVERSITY OF LEEDS   (United Kingdom)

^p AMERICAN CANCER SOCIETY   (United States)

^q VA BOSTON HEALTHCARE SYSTEM   (United States)

^r CANCER EPIDEMIOLOGY CENTRE   (Australia)

^s UNIVERSITY OF MELBOURNE   (Australia)

^t JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^u DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^v DIF   (France)

^w FONDATION JEAN DAUSSET CEPH   (France)

^x UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^y ASTRAZENECA R AND D   (Sweden)

^z Fred Hutchinson Cancer Research Center   (United States)

^aa UNIVERSITY OF WASHINGTON   (United States)

^ab PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^ac VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^ad UNIVERSITY HOSPITAL BONN   (Germany)

^ae HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^af JOHNS HOPKINS UNIVERSITY   (United States)

^ag NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ah SHANGHAI CANCER INSTITUTE   (China)

^ai UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2B; EPIDERMAL GROWTH FACTOR RECEPTOR; PHLDB1 PROTEIN; PROTEIN; RTEL PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ARTICLE; CHROMOSOME 11Q; CHROMOSOME 20Q; CHROMOSOME 5P; CHROMOSOME 7P; CHROMOSOME 8Q; CHROMOSOME 9P; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GLIOMA; HUMAN; META ANALYSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; CYCLIN-DEPENDENT KINASE INHIBITOR P15; DNA HELICASES; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GLIOBLASTOMA; GLIOMA; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TELOMERASE;

EID: 84870988159     PISSN: 03406717     EISSN: 14321203     Source Type: Journal    
DOI: 10.1007/s00439-012-1212-0     Document Type: Article

References (30)

1. Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS, Davis FG, Il'yasova D, Kruchko C, McCarthy BJ, Rajaraman P, Schwartzbaum JA, Sadetzki S, Schlehofer B, Tihan T, Wiemels JL, Wrensch M, Buffler PA (2008) Brain tumor epidemiology: Consensus from the Brain Tumor Epidemiology Consortium. Cancer 113:1953-1968
2. CBTRUS (2012) CBTRUS Statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2004-2008. Central Brain Tumor Registry of the United States (CBTRUS), Chicago, Illinois
3. Cancer Genome Atlas Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061-1068
4. Egan KM, Thompson RC, Nabors LB, Olson JJ, Brat DJ, Larocca RV, Brem S, Moots PL, Madden MH, Browning JE, Ann Chen Y (2011) Cancer susceptibility variants and the risk of adult glioma in a US case-control study. J Neurooncol 104:535-542
5. Falush D, Stephens M, Pritchard JK (2007) Inference of population structure using multilocus genotype data: Dominant markers and null alleles. Mol Ecol Notes 7:574-578
6. Farrell CJ, Plotkin SR (2007) Genetic causes of brain tumors: Neurofibromatosis, tuberous sclerosis, von Hippel-Lindau, and other syndromes. Neurol Clin 25:925-46 (viii
7. Hemminki K, Tretli S, Sundquist J, Johannesen TB, Granstrom C (2009) Familial risks in nervous-system tumours: A histologyspecific analysis from Sweden and Norway. Lancet Oncol 10:481-488
8. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE, Wacholder S, Wang Z, Welch R, Hutchinson A, Wang J, Yu K, Chatterjee N, Orr N, Willett WC, Colditz GA, Ziegler RG, Berg CD, Buys SS, McCarty CA, Feigelson HS, Calle EE, Thun MJ, Hayes RB, Tucker M, Gerhard DS, Fraumeni JF Jr, Hoover RN, Thomas G, Chanock SJ (2007) A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39:870-874
9. ICD-O (2000) International Classification of Diseases for Oncology, 3rd edn. World Heath Organization, Geneva
10. Jenkins RB, Wrensch MR, Johnson D, Fridley BL, Decker PA, Xiao Y, Kollmeyer TM, Rynearson AL, Fink S, Rice T, McCoy LS, Halder C, Kosel ML, Giannini C, Tihan T, O'Neill BP, Lachance DH, Yang P, Wiemels J, Wiencke JK (2011) Distinct germ line polymorphisms underlie glioma morphologic heterogeneity. Cancer Genet 204:13-18
11. Kohler BA, Ward E, McCarthy BJ, Schymura MJ, Ries LA, Eheman C, Jemal A, Anderson RN, Ajani UA, Edwards BK (2011) Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst 103:714-736
12. Lachance DH, Yang P, Johnson DR, Decker PA, Kollmeyer TM, McCoy LS, Rice T, Xiao Y, Ali-Osman F, Wang F, Stoddard SM, Sprau DJ, Kosel ML, Wiencke JK, Wiemels JL, Patoka JS, Davis F, McCarthy B, Rynearson AL, Worra JB, Fridley BL, O'Neill BP, Buckner JC, Il'yasova D, Jenkins RB, Wrensch MR (2011) Associations of high-grade glioma with glioma risk alleles and histories of allergy and smoking. Am J Epidemiol 174:574-581
13. Landi MT, Chatterjee N, Yu K, Goldin LR, Goldstein AM, Rotunno M, Mirabello L, Jacobs K, Wheeler W, Yeager M, Bergen AW, Li Q, Consonni D, Pesatori AC, Wacholder S, Thun M, Diver R, Oken M, Virtamo J, Albanes D, Wang Z, Burdette L, Doheny KF, Pugh EW, Laurie C, Brennan P, Hung R, Gaborieau V, McKay JD, Lathrop M, McLaughlin J, Wang Y, Tsao MS, Spitz MR, Krokan H, Vatten L, Skorpen F, Arnesen E, Benhamou S, Bouchard C, Metspalu A, Vooder T, Nelis M, Valk K, Field JK, Chen C, Goodman G, Sulem P, Thorleifsson G, Rafnar T, Eisen T, Sauter W, Rosenberger A, Bickeboller H, Risch A, Chang-Claude J, Wichmann HE, Stefansson K, Houlston R, Amos CI, Fraumeni JF Jr, Savage SA, Bertazzi PA, Tucker MA, Chanock S, Caporaso NE (2009) A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet 85:679-691
14. Louis DN, Ohgaki H, Wiestler OD, Cavanee WK (2007) WHO classification of tumors of the central nervous system. IARC Press, Lyons
15. Malmer B, Henriksson R, Gronberg H (2003) Familial brain tumours-genetics or environment? A nationwide cohort study of cancer risk in spouses and first-degree relatives of brain tumour patients. Int J Cancer 106:260-263
16. Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, Berman BP, Pan F, Pelloski CE, Sulman EP, Bhat KP, Verhaak RG, Hoadley KA, Hayes DN, Perou CM, Schmidt HK, Ding L, Wilson RK, Van Den Berg D, Shen H, Bengtsson H, Neuvial P, Cope LM, Buckley J, Herman JG, Baylin SB, Laird PW, Aldape K (2010) Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17:510-522
17. Park JH, Wacholder S, Gail MH, Peters U, Jacobs KB, Chanock SJ, Chatterjee N (2010) Estimation of effect size distribution from genome-wide association studies and implications for future discoveries. Nat Genet 42:570-575
18. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, Misra A, Nigro JM, Colman H, Soroceanu L, Williams PM, Modrusan Z, Feuerstein BG, Aldape K (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9:157-173
19. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38:904-909
20. Stacey SN, Sulem P, Jonasdottir A, Masson G, Gudmundsson J, Gudbjartsson DF, Magnusson OT, Gudjonsson SA, Sigurgeirsson B, Thorisdottir K, Ragnarsson R, Benediktsdottir KR, Nexo BA, Tjonneland A, Overvad K, Rudnai P, Gurzau E, Koppova K, Hemminki K, Corredera C, Fuentelsaz V, Grasa P, Navarrete S, Fuertes F, Garcia-Prats MD, Sanambrosio E, Panadero A, De Juan A, Garcia A, Rivera F, Planelles D, Soriano V, Requena C, Aben KK, van Rossum MM, Cremers RG, van Oort IM, van Spronsen DJ, Schalken JA, Peters WH, Helfand BT, Donovan JL, Hamdy FC, Badescu D, Codreanu O, Jinga M, Csiki IE, Constantinescu V, Badea P, Mates IN, Dinu DE, Constantin A, Mates D, Kristjansdottir S, Agnarsson BA, Jonsson E, Barkardottir RB, Einarsson GV, Sigurdsson F, Moller PH, Stefansson T, Valdimarsson T, Johannsson OT, Sigurdsson H, Jonsson T, Jonasson JG, Tryggvadottir L, Rice T, Hansen HM, Xiao Y, Lachance DH, Kosel ML, Decker PA, Thorleifsson G, Johannsdottir H, Helgadottir HT, Sigurdsson A, Steinthorsdottir V, Lindblom A, Sandler RS, Keku TO, Banasik K, Jorgensen T, Witte DR, Hansen T, Pedersen O, Jinga V, Neal DE, Catalona WJ, WrenschM,Wiencke J, JenkinsRB, Nagore E,VogelU,Kiemeney LA, Kumar R, Mayordomo JI, Olafsson JH, Kong A et al (2011) A germline variant in the TP53 polyadenylation signal confers cancer susceptibility. Nature genetics 43: 1098-1103
21. Sanson M, Hosking FJ, Shete S, Zelenika D, Dobbins SE, Ma Y, Enciso-Mora V, Idbaih A, Delattre JY, Hoang-Xuan K, Marie Y, Boisselier B, Carpentier C, Wang XW, Di Stefano AL, Labussiere M, Gousias K, Schramm J, Boland A, Lechner D, Gut I, Armstrong G, Liu Y, Yu R, Lau C, Di Bernardo MC, Robertson LB, Muir K, Hepworth S, Swerdlow A, Schoemaker MJ, Wichmann HE, Muller M, Schreiber S, Franke A, Moebus S, Eisele L, Forsti A, Hemminki K, Lathrop M, Bondy M, Houlston RS, Simon M (2011) Chromosome 7p11.2 (EGFR) variation influences glioma risk. Hum Mol Genet 20:2897-2904
22. Scheurer ME, Etzel CJ, Liu M, El-Zein R, Airewele GE, Malmer B, Aldape KD, Weinberg JS, Yung WK, Bondy ML (2007) Aggregation of cancer in first-degree relatives of patients with glioma. Cancer Epidemiol Biomarkers Prev 16:2491-2495
23. Schoemaker MJ, Robertson L, Wigertz A, Jones ME, Hosking FJ, Feychting M, Lonn S, McKinney PA, Hepworth SJ, Muir KR, Auvinen A, Salminen T, Kiuru A, Johansen C, Houlston RS, Swerdlow AJ (2010) Interaction between 5 genetic variants and allergy in glioma risk. Am J Epidemiol 171:1165-1173
24. Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malmer B, Simon M, Marie Y, Boisselier B, Delattre JY, Hoang-Xuan K, El Hallani S, Idbaih A, Zelenika D, Andersson U, Henriksson R, Bergenheim AT, Feychting M, Lonn S, Ahlbom A, Schramm J, Linnebank M, Hemminki K, Kumar R, Hepworth SJ, Price A, Armstrong G, Liu Y, Gu X, Yu R, Lau C, Schoemaker M, Muir K, Swerdlow A, Lathrop M, Bondy M, Houlston RS (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41:899-904
25. Simon M, Hosking FJ, Marie Y, Gousias K, Boisselier B, Carpentier C, Schramm J, Mokhtari K, Hoang-Xuan K, Idbaih A, Delattre JY, Lathrop M, Robertson LB, Houlston RS, Sanson M (2010) Genetic risk profiles identify different molecular etiologies for glioma. Clin Cancer Res 16:5252-5259
26. Wrensch M, Lee M, Miike R, Newman B, Barger G, Davis R, Wiencke J, Neuhaus J (1997) Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls. Am J Epidemiol 145:581-593
27. Wrensch M, Jenkins RB, Chang JS, Yeh RF, Xiao Y, Decker PA, Ballman KV, Berger M, Buckner JC, Chang S, Giannini C, Halder C, Kollmeyer TM, Kosel ML, LaChance DH, McCoy L, O'Neill BP, Patoka J, Pico AR, Prados M, Quesenberry C, Rice T, Rynearson AL, Smirnov I, Tihan T, Wiemels J, Yang P, Wiencke JK (2009) Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 41:905-908
28. Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, Friedman H, Friedman A, Reardon D, Herndon J, Kinzler KW, Velculescu VE, Vogelstein B, Bigner DD (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765-773
29. Yeager M, Orr N, Hayes RB, Jacobs KB, Kraft P, Wacholder S, Minichiello MJ, Fearnhead P, Yu K, Chatterjee N, Wang Z, Welch R, Staats BJ, Calle EE, Feigelson HS, Thun MJ, Rodriguez C, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Giovannucci E, Willett WC, Cancel-Tassin G, Cussenot O, Valeri A, Andriole GL, Gelmann EP, Tucker M, Gerhard DS, Fraumeni JF Jr, Hoover R, Hunter DJ, Chanock SJ, Thomas G (2007) Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 39:645-649
30. Yu K, Wang Z, Li Q, Wacholder S, Hunter DJ, Hoover RN, Chanock S, Thomas G (2008) Population substructure and control selection in genome-wide association studies. PLoS ONE 3:e2551